Glow Blend

Researchers studying skin, connective tissue, and recovery pathways often investigate these three peptides together because their proposed mechanisms are complementary rather than overlapping: GHK-Cu is studied for its role in collagen synthesis and dermal signaling, BPC-157 for angiogenesis and gut/tendon repair models, and TB-500 for actin regulation and cell migration. Combining them into a single vial is a formulation convenience for researchers running protocols that call for all three, rather than evidence that the combination has been studied as a unit more than the individual compounds have.

Vendors most commonly sell Glow Blend as a 70 mg vial split 50 mg GHK-Cu / 10 mg BPC-157 / 10 mg TB-500, though exact ratios and total mg can vary by vendor — always check the listed composition on the vendor's product page and certificate of analysis rather than assuming a standard split. Some vendors offer smaller sizes (e.g., a 50 mg total blend) with a proportionally scaled-down ratio.

Reconstitution involves adding a measured volume of bacteriostatic water to the lyophilized peptide powder to reach a target concentration — for example, a 70 mg vial mixed with 2 mL of bacteriostatic water yields a 35 mg/mL solution. The exact volume used should match the concentration called for in your research protocol; use a sterile syringe and inject the water slowly down the vial wall rather than directly onto the powder to avoid degrading the peptides. A dosage/reconstitution calculator can help convert vial size and water volume into per-unit amounts.